Paul Tudor Jones’s scPharmaceuticals SCPH Stock Holding History

Paul Tudor Jones’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,150,000	Closed	-$12.2M	–	3992
2025 Q3	$12.2M	Buy	+2,150,000	New	+$11M	0.02%	660

Paul Tudor Jones's SCPH Position: Q4 2025 in Review

Paul Tudor Jones sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 2,150,000 shares — an estimated $12.2M sold.

Paul Tudor Jones first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $12.2M in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

Paul Tudor Jones reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
Paul Tudor Jones sold 2,150,000 scPharmaceuticals shares in Q4 2025, an estimated $12.2M.
Paul Tudor Jones first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
Paul Tudor Jones's scPharmaceuticals position peaked at $12.2M in Q3 2025.
0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.